Did you know?

Verastem (NASDAQ: VSTM) just reported results for the fourth quarter of 2023. Verastem reported earnings per share of -$1.10. This was below the analyst estimate for EPS of -62 cents.Get the latest Syros Pharmaceuticals Inc (SYRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Verastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. Founded: 2010. CEO: Brian Stuglik (Jul 2019–)Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle ...Track Microstrategy Inc. (MSTR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Join Us. At Verastem Oncology, every team member plays a key role in helping to develop novel cancer therapies in areas of high unmet need. If you're looking to make a difference for patients at a company where you'll constantly be challenged, where professional career growth is a priority, where you'll always be heard, and where our ...Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Track Sagimet Biosciences Inc (SGMT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsPublished: May 23, 2024 at 6:47 p.m. ET. By Ben Glickman. Shares of Verastem rose late Thursday after interim data from the company's trial evaluating a …View Verastem, Inc VSTM investment & stock information. Get the latest Verastem, Inc VSTM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Track VERSES Technologies Inc - Ordinary Shares - Class A (Sub Voting) (VRSSF) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMizuho Securities analyst Mara Goldstein maintained a Hold rating on Verastem (VSTM – Research Report) today and set a price target of $24.00.The company’s shares closed yesterday at $1.02 ...Track Aeva Technologies Inc (AEVA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBOSTON--(BUSINESS WIRE)--Sep. 5, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the Company will participate in the following upcoming investor conferences: . H.C. Wainwright 25 th Annual Global Investment Conference; podium presentation on Tuesday, September 12, 2023 at 2:00 p.m. ETVerastem trades at a near all-time low, so it's the perfect moment to analyze the risks and rewards of this investment. The company has a strong distribution network to sustain high growth levels ...BOSTON, December 13, 2023--Verastem Oncology (Nasdaq: VSTM) (the "Company"), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that it has ...Track Ekso Bionics Holdings Inc (EKSO) Stock Price, Quote, latStocktwits is the leading social platform for investors and tr 6 days ago · View Verastem, Inc VSTM investment & stock information. Get the latest Verastem, Inc VSTM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Track Actinium Pharmaceuticals Inc (ATNM) Stock Pri Verastem's (VSTM) avutometinib/Lumakras combination therapy gets the FDA's Fast Track designation to treat KRAS G12C-mutant metastatic NSCLC patients. The stock gains 8% in response. NEW YORK, Jan. 12, 2024 (GLOBE NEWSWIRE) -- In co

Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and ...We would like to show you a description here but the site won't allow us.2 days ago · Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer. BOSTON-- (BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that it has ...Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Veru is a biopharmaceutical company focused on developing novel medicines for high-quality weight loss, breast cancer, and viral related ARDS

Track Everspin Technologies Inc (MRAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBOSTON--(BUSINESS WIRE)--May 31, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock.Verastem’s stockholders approved an ……

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Verastem Oncology (Nasdaq: VSTM) is a late-stage developm. Possible cause: The stock options have an exercise price equal to $8.30 per share, the closin.